Garrick Wang
Psychiatry · Menlo Park, CANPI 1700099728
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 662 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 662 payments — averaging $22.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Axsome Therapeutics, Inc.$1K
- Lundbeck LLC$1K
- Otsuka America Pharmaceutical, Inc.$1K
- plus $4K from 15 others
What the payments were for
- Food & beverage$14,955100%
- Education$690%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 172 | $2,949 |
| Takeda Pharmaceuticals U.S.A., Inc. | 71 | $1,980 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 66 | $1,722 |
| Axsome Therapeutics, Inc. | 45 | $1,439 |
| Lundbeck LLC | 59 | $1,358 |
| Otsuka America Pharmaceutical, Inc. | 63 | $1,114 |
| Sunovion Pharmaceuticals Inc. | 49 | $890 |
| Alkermes, Inc. | 36 | $865 |
| Vanda Pharmaceuticals Inc. | 23 | $603 |
| Neurocrine Biosciences, Inc. | 12 | $405 |
| Almatica Pharma LLC | 13 | $355 |
| Teva Pharmaceuticals USA, Inc. | 8 | $259 |
| Jazz Pharmaceuticals Inc. | 9 | $203 |
| Johnson & Johnson | 8 | $199 |
| Idorsia Pharmaceuticals US Inc | 7 | $157 |
| Shire North American Group Inc | 5 | $142 |
| Indivior Inc. | 5 | $138 |
| Merck | 5 | $100 |
| E.r. Squibb & Sons, L.L.C. | 3 | $69 |
| Bausch Health US, LLC | 2 | $57 |
| Eisai Inc. | 1 | $22 |
How this compares
$15,024 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TopamaxTopiramate | 13 | $27,563 |
| AuvelityDextromethorphan Hbr/Bupropion | 12 | $12,470 |
| Doxepin Hcl | 12 | $5,829 |
| Lurasidone Hcl | 16 | $5,290 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 23 | $2,193 |
| Olanzapine | 29 | $1,193 |
| Vilazodone Hcl | 15 | $1,148 |
| Duloxetine Hcl | 26 | $1,013 |
| Bupropion XlBupropion Hcl | 41 | $816 |
| Lamotrigine | 27 | $535 |
| Lithium Carbonate ErLithium Carbonate | 17 | $509 |
| Lorazepam | 39 | $358 |
| Benztropine Mesylate | 12 | $281 |
| Clonazepam | 43 | $218 |
| Trazodone Hcl | 28 | $214 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Axsome Therapeutics, Inc.Auvelity | $1,439 | $12,47012 claims |
| Almatica Pharma LLCSertraline Hcl | $355 | $5624 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Menlo Park
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.